Go Pro

Protara Therapeutics (TARA) News Today

Protara Therapeutics logo
$3.97 +0.10 (+2.58%)
Closing price 08/25/2026 04:00 PM Eastern
Extended Trading
$3.98 +0.00 (+0.13%)
As of 08/25/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Protara Therapeutics Latest News

HC Wainwright Has Pessimistic Outlook of TARA Q3 Earnings
Protara Therapeutics stock tumbles on trial data release
Protara Announces Closing of $75 Million Public Offering
Protara Announces Closing of $75 Million Public Offering

Protara Therapeutics Media Mentions By Week

Protara Therapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TARA
News Sentiment

-1.36

0.68

Average
Healthcare
News Sentiment

Protara Therapeutics News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TARA Articles
This Week

2

3

TARA Articles
Average Week

Protara Therapeutics Trends on MarketBeat

This week vs. last week
New Followers
1
-50%
Searches
1
Page Views
2,066
-13%
Get Protara Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TARA and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Protara Therapeutics dated 8/21/2026.
From Our Partners